Journal
DIABETES CARE
Volume 41, Issue 12, Pages 2648-2668Publisher
AMER DIABETES ASSOC
DOI: 10.2337/dci18-0052
Keywords
-
Categories
Funding
- Eli Lilly
- Novo Nordisk
- Johnson Johnson
- AstraZeneca